Andes hantavirus outbreak in cruise ship
This page is updated as more information becomes available. It was last updated 11 June at 13:05.
On 2 May 2026, ECDC was notified of a cluster of severe respiratory illness on MV Hondius, a Dutch-flagged cruise ship with passengers and crew from 23 countries, including nine EU/EEA countries. The virus has been identified as Andes hantavirus.
As of 11 June 2026, 13 cases have been reported in total, including 12 confirmed and one probable case.
Since the last update on 26 May 2026, one of the previously reported probable cases was reclassified as confirmed following positive laboratory result for hantavirus infection.
The identification of additional cases after former passengers and crew returned to their home country is possible given the long incubation period of Andes hantavirus and the possibility that some infections occurred on board on the ship. The risk to the EU/EEA general population remains very low.
Key information
Latest news
Guidance
Notes
*Suspected case: Anyone who shared or visited a conveyance where there has been a confirmed or probable ANDV case OR anyone who has been in contact with a probable or confirmed ANDV case AND with acute (or history of) symptoms compatible with ANDV infection, including fever (38°C or above), myalgia, chills, acute gastrointestinal (e.g. nausea, vomiting, diarrhoea, abdominal pain) or acute respiratory (e.g. cough, shortness of breath, chest pain, difficulty breathing) symptoms.
**Probable case: A person with signs and symptoms of a suspected case AND a known epidemiological link with a confirmed or probable ANDV case.
***Confirmed case: A person with laboratory confirmation of ANDV through PCR and/or by serology.
Non-case: A suspected or probable case who tests negative for ANDV by PCR and/or serology.
Laboratory support
The European Commission designates EU Reference Laboratories (EURLs) in public health to support national reference laboratories in improving diagnostics, testing methods, and surveillance of serious cross-border health threats.